Impact of Guided Biofilm Therapy on Epithelial and Mesenchymal Biomarkers in Periodontitis Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Root surface debridement, Guided Biofilm Therapy.
- Who it may be relevant to
- Registry conditions: Periodontitis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Iraq
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of Guided Biofilm Therapy on Gingival Crevicular Fluid Epithelial and Mesenchymal Biomarkers in Periodontitis Patients: A Randomized Controlled Clinical Trial
Overview
The goal of this clinical trial is to investigate the clinical and biochemical effects of the guided biofilm therapy protocol as an alternative to the conventional non-surgical periodontal therapy in patients with periodontitis. The main question it aims to answer is: Does the guided biofilm therapy (GBT) protocol have an impact on gingival crevicular fluid (GCF) epithelial and mesenchymal biomarkers in patients with periodontitis? All patients will be instructed to brush their teeth twice daily and will be supplied with the same type of toothpaste and toothbrush, with suitable interdental aids. All patients will be instructed to attend again after 7 days. At baseline, full-mouth periodontal charting and radiographs will be obtained and after 1-hour, GCF samples will be collected from both test and control groups. Sites allocated to control group will undergo supragingival debridement by using ultrasonic device. After one week, the control group will receive RSD using area specific (Gracey) curettes (Medesy, Italy) according to the 24-hours protocol and will receive teeth polishing by using rubber polishing cups and tooth polishing paste, while the test group will receive a full GBT protocol which includes eight steps: (1) ASSESS, (2) DISCLOSE, (3) MOTIVATE, (4) AIRFLOW, (5) PERIOFLOW, (6) PIEZON PS\*, (7) CHECK, and (8) RECALL. After finishing the treatment session, the patients will be asked to attend for follow up, clinical evaluation of PI, BOP, PPD, and CAL, and GCF samples collection after 1 month and 3 months.
Interventions
- Procedure Root surface debridement
Control group sites that will receive conventional NSPT will undergo supragingival debridement by using ultrasonic device at baseline. After one week, sites will receive root surface debridement (RSD) using area specific (Gracey) curettes (Medesy, Italy) according to the 24-hours protocol. - Device Guided Biofilm Therapy
Test group sites will receive guided biofilm therapy (GBT) protocol using the Airflow Prophylaxis Master device by EMS which includes EMS DISCLOSING AGENT making the biofilm visible, EMS AIRFLOW combined with PLUS erythritol powder for removing biofilm, discoloration, and early calculus, PERIOFLOW removing the biofilm in deep periodontal pockets gently and thoroughly, and finally PIEZON PS for removing the remaining calculus.
Primary outcome measures
- Change in probing pocket depth (PPD) [Time frame: 3 months]
Secondary outcome measures (4)
- Clinical attachment level (CAL) [Time frame: 3 months]
- Bleeding on probing (BOP) [Time frame: 3 months]
- Plaque index (PI) [Time frame: 3 months]
- Levels of gingival crevicular fluid (GCF) biomarkers [Time frame: 3 months]
Eligibility criteria
Inclusion criteria
- Adult subjects (>18 years).
- Subjects are not currently under active periodontal therapy or joining other trial in the last 3 months.
- Patients must be diagnosed with generalized unstable periodontitis with bilateral, symmetrical distribution of PPD ≥ 4mm and positive BOP.
\-
Exclusion criteria
- Patients not diagnosed with periodontitis.
- Patients consuming antibiotics.
- Regular users of nonsteroidal anti-inflammatory drugs (NSAIDs).
- Patients receiving periodontal treatment 3-months prior to the study.
- Pregnant or mothers in a breastfeeding period.
- Third molars and teeth with furcation involvement.
- Patients taking antioxidant supplements.
- Patients with heavy calculus that would prevent PerioPaper strips entrance to the periodontal pocket.
- Patient with pulmonary diseases and with a history of allergy to erythritol.
- Patients not willing to participate. -
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Iraq · 1 center
- College of Dentistry, University of Baghdad — Baghdad
Identifiers
NCT: NCT07286916 · 1108625